Skip to main content

Verónica Villagrasa Araya

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Verónica Villagrasa Araya

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Related news

Docetaxel, carried by Soluplus, proved to be the most effective and least toxic combination to cross the blood-brain barrier and attack the tumour directly.

Based on the study led by VHIR, a clinical trial has been approved for patients with locally advanced pancreatic cancer.

Vall d'Hebron participates in a project to develop innovative microsampling technology, making blood collection more accessible and patient-centered.

Related professionals

Carles Zafon Llopis

Carles Zafon Llopis

Main researcher
Diabetes and Metabolism
Read more
Immaculada Pérez Gladiador

Immaculada Pérez Gladiador

Administrative
Ethics Committees Support Unit (USCE)
External Strategy Directorate
Read more
Zaira Nieto Fernández

Zaira Nieto Fernández

Predoctoral researcher
Psychiatry, Mental Health and Addictions
Read more
Alfons Macaya Ruíz

Alfons Macaya Ruíz

Head of group
Pediatric Neurology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.